M. İhsan Han

612 total citations
26 papers, 493 citations indexed

About

M. İhsan Han is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, M. İhsan Han has authored 26 papers receiving a total of 493 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Organic Chemistry, 8 papers in Molecular Biology and 5 papers in Pharmacology. Recurrent topics in M. İhsan Han's work include Synthesis and biological activity (18 papers), Synthesis and Characterization of Heterocyclic Compounds (6 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (5 papers). M. İhsan Han is often cited by papers focused on Synthesis and biological activity (18 papers), Synthesis and Characterization of Heterocyclic Compounds (6 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (5 papers). M. İhsan Han collaborates with scholars based in Türkiye, Italy and New Zealand. M. İhsan Han's co-authors include Ş. Güniz Küçükgüzel, Gizem Bulut, Sevil Şenkardeş, Nalan İmamoğlu, Serkan Dayan, Ahmet Cumaoğlu, Miyase Gözde Gündüz, Özge Çevik, Ömer Aydın and Şengül Dilem Doğan and has published in prestigious journals such as Tetrahedron, Bioorganic & Medicinal Chemistry and New Journal of Chemistry.

In The Last Decade

M. İhsan Han

25 papers receiving 486 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. İhsan Han Türkiye 13 333 132 76 63 51 26 493
Rajnish Kumar India 12 338 1.0× 172 1.3× 53 0.7× 33 0.5× 44 0.9× 82 557
Umasankar Kulandaivelu India 12 206 0.6× 151 1.1× 49 0.6× 62 1.0× 34 0.7× 63 459
Nilanchala Sahu India 5 374 1.1× 133 1.0× 79 1.0× 39 0.6× 40 0.8× 9 534
Alicja Urbaniak United States 13 198 0.6× 131 1.0× 33 0.4× 82 1.3× 43 0.8× 30 443
Saloni Kakkar India 14 414 1.2× 214 1.6× 45 0.6× 40 0.6× 43 0.8× 31 691
Chatchakorn Eurtivong Thailand 15 187 0.6× 224 1.7× 65 0.9× 43 0.7× 34 0.7× 41 468
Ruo‐Jun Man China 14 266 0.8× 194 1.5× 74 1.0× 36 0.6× 35 0.7× 30 476
Seyedeh Mahdieh Hashemi Iran 13 338 1.0× 121 0.9× 51 0.7× 29 0.5× 42 0.8× 23 513
Barbara Kaproń Poland 14 378 1.1× 238 1.8× 85 1.1× 49 0.8× 57 1.1× 33 643
Santosh N. Mokale India 15 340 1.0× 195 1.5× 68 0.9× 47 0.7× 93 1.8× 52 622

Countries citing papers authored by M. İhsan Han

Since Specialization
Citations

This map shows the geographic impact of M. İhsan Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. İhsan Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. İhsan Han more than expected).

Fields of papers citing papers by M. İhsan Han

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. İhsan Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. İhsan Han. The network helps show where M. İhsan Han may publish in the future.

Co-authorship network of co-authors of M. İhsan Han

This figure shows the co-authorship network connecting the top 25 collaborators of M. İhsan Han. A scholar is included among the top collaborators of M. İhsan Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. İhsan Han. M. İhsan Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Peiyao, Yingying Gu, M. İhsan Han, et al.. (2025). Discovery of novel antiviral and antifungal agents based on flavonoid derivatives. Bioorganic Chemistry. 167. 109280–109280.
2.
3.
Han, M. İhsan, et al.. (2024). Synthesis of new 4-aminobenzoic acid (PABA) hydrazide-hydrazone/sulfonate hybrids and antimicrobial evaluation with ascorbic acid/salicylic acid/ N -acetyl cysteine combinations. Phosphorus, sulfur, and silicon and the related elements. 199(4). 316–323. 2 indexed citations
4.
Doğan, Şengül Dilem, Yasin Çetinkaya, M. İhsan Han, et al.. (2023). Linking quinoline ring to 5-nitrofuran moiety via sulfonyl hydrazone bridge: Synthesis, structural characterization, DFT studies, and evaluation of antibacterial and antifungal activity. Journal of Molecular Structure. 1292. 136155–136155. 10 indexed citations
5.
6.
Han, M. İhsan & Nalan İmamoğlu. (2023). Design, Synthesis, and Anticancer Evaluation of Novel Tetracaine Hydrazide-Hydrazones. ACS Omega. 8(10). 9198–9211. 20 indexed citations
7.
Han, M. İhsan, et al.. (2023). Investigation of Gold Nanoparticle Naproxen-Derived Conjugations in Ovarian Cancer. ACS Materials Au. 3(5). 483–491. 7 indexed citations
8.
Şenkardeş, Sevil, et al.. (2022). Synthesis and anticancer activity of novel hydrazone linkage-based aryl sulfonate derivatives as apoptosis inducers. Medicinal Chemistry Research. 31(2). 368–379. 37 indexed citations
9.
Han, M. İhsan, et al.. (2022). Synthesis, antimicrobial evaluation and molecular modeling studies of novel thiosemicarbazides/semicarbazides derived from p-aminobenzoic acid. Journal of Molecular Structure. 1261. 132907–132907. 11 indexed citations
10.
Han, M. İhsan, et al.. (2022). Investigation of Antimicrobial Activity of Some Ethylparaben Hydrazide-Hydrazone Derivatives. Turkish Journal of Pharmaceutical Sciences. 20(1). 35–38. 2 indexed citations
11.
Han, M. İhsan, Vagolu Siva Krishna, Cagatay Dengiz, et al.. (2022). Isoniazid Linked to Sulfonate Esters via Hydrazone Functionality: Design, Synthesis, and Evaluation of Antitubercular Activity. Pharmaceuticals. 15(10). 1301–1301. 18 indexed citations
12.
Han, M. İhsan, Ömer Erdoğan, Gökhan Ünal, et al.. (2022). Design, synthesis, and in vitro and in vivo anticancer activity studies of new (S)-Naproxen thiosemicarbazide/1,2,4-triazole derivatives. New Journal of Chemistry. 46(13). 6046–6059. 12 indexed citations
13.
Han, M. İhsan, et al.. (2022). Design, synthesis and anticancer activity studies of novel 4-butylaminophenyl hydrazide-hydrazones as apoptotic inducers. Tetrahedron. 115. 132797–132797. 15 indexed citations
14.
Han, M. İhsan, et al.. (2021). Design and synthesis of novel (S)-Naproxen hydrazide-hydrazones as potent VEGFR-2 inhibitors and their evaluation in vitro/in vivo breast cancer models. Bioorganic & Medicinal Chemistry. 37. 116097–116097. 47 indexed citations
15.
Han, M. İhsan, et al.. (2021). Isoquinolinedione-urea hybrids: Synthesis, antibacterial evaluation, drug-likeness, molecular docking and DFT studies. Journal of Molecular Structure. 1252. 132007–132007. 13 indexed citations
16.
Han, M. İhsan, et al.. (2020). Synthesis, characterization and anticancer activity of novel hydrazide-hydrazones derived from ethyl paraben. Journal of Research in Pharmacy. 24(3). 341–349. 14 indexed citations
17.
Han, M. İhsan & Ş. Güniz Küçükgüzel. (2020). Anticancer and Antimicrobial Activities of Naproxen and Naproxen Derivatives. Mini-Reviews in Medicinal Chemistry. 20(13). 1300–1310. 38 indexed citations
18.
Şenkardeş, Sevil, M. İhsan Han, Mürüvvet Abbak, et al.. (2019). Synthesis, molecular docking and evaluation of novel sulfonyl hydrazones as anticancer agents and COX-2 inhibitors. Molecular Diversity. 24(3). 673–689. 55 indexed citations
19.
Han, M. İhsan, et al.. (2018). Synthesis and characterization of 1,2,4-triazole containing hydrazide-hydrazones derived from (S)-naproxen as anticancer agents. Journal of Research in Pharmacy. 22(1). 229–239. 27 indexed citations
20.
Han, M. İhsan & Gizem Bulut. (2015). The folk-medicinal plants of Kadişehri (Yozgat – Turkey). Acta Societatis Botanicorum Poloniae. 84(2). 237–248. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rajnish Kumar Breakdown of academic impact, for papers by Umasankar Kulandaivelu Breakdown of academic impact, for papers by Nilanchala Sahu Breakdown of academic impact, for papers by Alicja Urbaniak Breakdown of academic impact, for papers by Saloni Kakkar Breakdown of academic impact, for papers by Chatchakorn Eurtivong Breakdown of academic impact, for papers by Ruo‐Jun Man Breakdown of academic impact, for papers by Seyedeh Mahdieh Hashemi Breakdown of academic impact, for papers by Barbara Kaproń Breakdown of academic impact, for papers by Santosh N. Mokale
Rankless by CCL
2026